Showing 12 RESULTS FOR
Mental health
Research Update: Tackling Schizophrenia’s Most Debilitating Symptoms
Lundbeck's Dr. Bruce Kinon on the challenges related to treating negative symptoms of schizophrenia and new directions in negative-symptom research.
0
New Study Used Personalized Goals to Assess Treatment Effectiveness for Patients with Major Depressive Disorder
Results from an open-label study evaluating the development and assessment of personalized goals as a way of measuring treatment effectiveness in MDD.
4
Data Demonstrate Safety and Efficacy of Brexpiprazole in Patients With Schizophrenia Experiencing Severe Psychotic Symptoms
Study on the safety and efficacy of brexpiprazole in the treatment of patients with schizophrenia experiencing severe psychotic symptoms during an acute episode. Severity of symptoms can be a significant predictor of poor treatment outcomes.
3
One Hidden Hurdle Facing Women in the Workplace
Research shows that 83 percent of women find depression to be a top barrier to workplace success. “This is one barrier to women’s success that we can – and should – take on,” writes Sally Benjamin Young, Lundbeck’s Vice President of Public Affairs.
183
Preserving Our Future: Confronting the Link Between the Opioid Crisis and Mental Health
Peter Anastasiou, Executive Vice President and Head of Lundbeck North America, addresses the link between mental health and the opioid crisis in a recent article. He highlights policies he believes are essential to addressing the problems of untreated mental illness and widespread opioid addiction.
121